Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus.
about
Factors associated with coronary artery calcification in young female patients with SLE.Nephritis and the risk of acute myocardial infarction in patients with systemic lupus erythematosusClinical implications and prognostic significance of thrombocytopenia in Tunisian patients with systemic lupus erythematosus.Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort.Thrombocytopenia in Systemic Lupus Erythematosus: Clinical Manifestations, Treatment, and Prognosis in 230 Patients.Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and futureUnderstanding the epidemiology and progression of systemic lupus erythematosusDifference in clinical presentation between women and men in incident primary Sjögren's syndrome.Cathepsin S inhibition combines control of systemic and peripheral pathomechanisms of autoimmune tissue injury.Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study.Renal transplantation in systemic lupus erythematosus: outcome and prognostic factors in 50 cases from a single centre.New classification criteria for systemic lupus erythematosus correlate with disease activityTh17-related cytokines in systemic lupus erythematosus patients with dilated cardiomyopathies: a possible linkage to parvovirus B19 infection.Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease.Immunotherapy for autoimmune and inflammatory renal diseases.The Steroids In the Maintenance of remission of Proliferative Lupus nephritis (SIMPL) pilot trialPrevalence of the American College of Rheumatology classification criteria in a group of 162 systemic lupus erythematosus patients from Croatia.Unmet medical needs in lupus nephritis: solutions through evidence-based, personalized medicineVasculitis: mechanisms involved and clinical manifestationsThrombosis in systemic lupus erythematosus: a review articleThe Level of IgA Antibodies to Endothelial Cells Correlates with Histological Evidence of Disease Activity in Patients with Lupus Nephritis.Gene expression studies in systemic lupus erythematosus.Outcome and predictors of kidney disease progression in Puerto Ricans with systemic lupus erythematosus initially presenting with mild renal involvement.Pulmonary embolism in an adolescent girl with negative ACLA systemic lupus erythematosus (SLE): a case report.Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus.Review: Male systemic lupus erythematosus: a review of sex disparities in this disease.Beyond the LUNAR trial. Efficacy of rituximab in refractory lupus nephritis.Global trends, potential mechanisms and early detection of organ damage in SLE.Neonatal congenital heart block.Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus.Immunopathology of lupus nephritis.Treat-to-target in systemic lupus erythematosus: recommendations from an international task force.Long-term follow-up in primary Sjögren's syndrome reveals differences in clinical presentation between female and male patientsRisk of end-stage renal disease in systemic lupus erythematosus patients: a nationwide population-based study.Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis.Analysis of disease activity and response to treatment in a large Spanish cohort of patients with systemic lupus erythematosus.[Prognosis and therapy of inflammatory rheumatic diseases : Impact of renal manifestations].Lack of association of mannose binding lectin variant alleles with systemic lupus erythematosus.Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic Lupus erythematosus.Survival rates and risk factors for mortality in systemic lupus erythematosus patients in a Chinese center.
P2860
Q33188178-3FA08EA7-2425-4E05-82C2-C42E2D8CE277Q33389669-CA0C4B54-FB13-4B9D-920D-5238FA0667EFQ33399850-B666A384-D05B-4B8A-8DE6-7966C2A6A72DQ33411232-95445319-F3C8-4426-88F4-E6965095513AQ33429997-83F225C0-8979-4106-BA8F-7546C3622F55Q33601679-9273A48F-ED60-4700-B23D-2E5F87D0ABD1Q33621131-73B0D886-9599-42E8-AD6E-B30C967258DDQ33668163-A7A7E0ED-8A2B-4388-B02E-C293965557DAQ33765990-8E56C8CD-AC07-45F3-AF34-0BC3ED8BB44CQ33766242-83410568-3B1F-4609-BCB4-98AD1EECC3A9Q33810462-D22454DA-A9A6-4CC7-8E20-1B227A4B115CQ34492782-161F0639-B8D4-4BC2-AFCB-85AD2D056E17Q34612207-5F68EF28-CE2C-4B34-AF22-497B348E410AQ35126686-F1901DA3-D641-434D-9F69-2C4F8624A1A4Q35144046-702DCE22-A075-4A15-A97F-4CC42D082436Q35147352-200BD1EA-6B13-4A9F-B624-BBABB35204B4Q35929317-81531B0C-F347-49F3-B2A9-A778D1893081Q36088877-2CC42489-0C74-4979-9E20-E20E2C8D5CA7Q36130959-26B7290D-DE66-4E2B-8B55-E17F401D3800Q36147794-5FAE254A-1E56-4951-A7EC-4B8C8F4EEB29Q36176022-E50358B8-396D-4435-8352-AA10012C2186Q36560799-E30E6885-4A21-49C5-B989-DC8E4B443967Q36600357-68CEAD49-CDE1-4190-9D31-DDF340EF5C18Q36766604-F2C6AD4B-0A32-45AC-8F2B-645237C07B38Q37127464-D83843C4-E351-4E78-A57C-120856407C55Q37640958-5AB991F2-A339-44D0-97AE-F6264AA4BD26Q38024085-9F0FC315-8AC6-4B28-AAD8-018B76BB1323Q38066385-0C9661E4-A704-40FB-9BAC-2A27BB4C7D27Q38115436-6A2CDD99-341B-4C91-97B3-3395EDAA100AQ38162490-53EF8CC8-54DD-40F8-B678-C8857A12783BQ38176819-2E55BFD1-B092-4B58-85CD-5699AAECCF38Q38205079-09639E91-DBB9-4991-AE12-1578851B25ADQ38633508-CDF109F5-30BF-45A8-9D6D-2A6F2C365386Q40006983-1A8BE652-7FD2-4368-9D1C-9E572B69FCCCQ40817900-B07DE8FC-D7A6-4284-8005-90933B70D2B8Q41680597-4A45F542-6F0D-4CA4-90A8-D47448FE6F20Q41746643-F64CF449-1EEA-4B96-BF8E-F4A9C03B8823Q42956271-CBFF8579-B1FC-492B-AA17-DCE94903BA3CQ43427893-12FE1792-5630-446A-AC50-A3499484A39FQ43468721-8A8DB1DD-96BD-421B-AF9D-F10A68532CFB
P2860
Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Definition of risk factors for ...... systemic lupus erythematosus.
@ast
Definition of risk factors for ...... systemic lupus erythematosus.
@en
type
label
Definition of risk factors for ...... systemic lupus erythematosus.
@ast
Definition of risk factors for ...... systemic lupus erythematosus.
@en
prefLabel
Definition of risk factors for ...... systemic lupus erythematosus.
@ast
Definition of risk factors for ...... systemic lupus erythematosus.
@en
P2093
P2860
P356
P1476
Definition of risk factors for ...... systemic lupus erythematosus.
@en
P2093
Geisselbrecht M
Pfahlberg A
P2860
P304
P356
10.1136/ARD.61.12.1065
P407
P577
2002-12-01T00:00:00Z